LabPulse.com staff writersPCRQiagen partners with FBI on forensics assayQiagen has announced a collaboration with the FBI to develop a new assay to improve DNA quantification for use in forensics and human identification.May 8, 2024ImmunoassaysUniversity of Florida researchers develop CRISPR-based assay for HPV detectionResearchers at the University of Florida have developed a testing method that utilizes CRISPR gene-editing technology to detect HPV in blood or saliva samples that could promote earlier cervical cancer detection.May 7, 2024FDA ClearanceGeneoscopy receives FDA approval for CRC screening testGeneoscopy announced that the U.S. Food and Drug Administration (FDA) has approved ColoSense, the firm's noninvasive multitarget stool RNA colorectal cancer (CRC) screening test.May 7, 2024FinancingKarius raises $100M in series C fundingDiagnostics firm Karius has secured $100 million in series C funding in a recent financing round.May 6, 2024CollaborationNovo Nordisk Foundation, Wellcome, Gates Foundation to partner on global health challengesThe Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have announced a collaboration to support scientific research and development for accessible solutions to global health challenges.May 6, 2024Trends and FinanceCue Health to cut 230 jobs in restructuring planIn a filing with the U.S. Securities and Exchange Commission, Cue Health said it intends to cut 230 jobs, 49% of its workforce, as part of a cost-reduction plan the firm is implementing.May 3, 2024CollaborationAstellas and Poseida to collaborate on oncology cell therapiesPoseida Therapeutics and Astellas, under its Xyphos Biosciences subsidiary, have initiated a research collaboration and licensing agreement to develop allogeneic cell therapy programs by combining their innovative cell therapy platforms and technologies.May 2, 2024FDA ClearanceLeica Biosystems, Sectra receive FDA 510(k) clearance for digital pathology systemLeica Biosystems has received 510(k) clearance from the U.S Food and Drug Administration (FDA) for its Aperio GT 450 DX digital pathology system, in conjunction with Sectra's digital pathology software.May 2, 2024Research AllianceGSK, Genomics PLC collaborate on polygenic risk score use for clinical trialsGenomics PLC and biopharmaceutical firm GSK have established a collaboration aimed at assessing the potential for using polygenic risk scores in clinical trials.May 1, 2024Pathology and AIQuest Diagnostics to add digital pathology lab, AI pathology center in TennesseeQuest Diagnostics said it will acquire PathAI Diagnostics in Memphis, TN, the business of PathAI that provides anatomic and digital pathology laboratory services, to accelerate the adoption of digital and AI pathology.May 1, 2024Previous PagePage 2 of 342Next PageTop StoriesArtificial IntelligenceBacklog of unresolved medical diagnoses leads to new method for clinical exome reanalysisThe automated analysis improved the rate of accurate genetic diagnosis, doubling the number of solved cases as compared with benchmarked methods, across three distinct real-world cohorts, according to researchers.FDA Warning LetterFDA issues warning for Cue Health COVID-19 testsEmerging TechnologyBiomarker extraction through ultrasound shows promise for cancer detectionTrends and FinanceNorthwell Health Cancer Institute opens molecular diagnostics laboratorySponsor ContentVisit our Molecular Diagnostics Community